Mohamad Navab

Mohamad Navab

UNVERIFIED PROFILE

Are you Mohamad Navab?   Register this Author

Register author
Mohamad Navab

Mohamad Navab

Publications by authors named "Mohamad Navab"

Are you Mohamad Navab?   Register this Author

100Publications

2063Reads

22Profile Views

Role of enterocyte stearoyl-Co-A desaturase-1 in LDLR-null mice.

J Lipid Res 2018 10 23;59(10):1818-1840. Epub 2018 Aug 23.

Departments of Medicine, University of California-Los Angeles, Los Angeles, CA 90095.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1194/jlr.M083527DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168294PMC
October 2018

Oral Apolipoprotein A-I Mimetic D-4F Lowers HDL-Inflammatory Index in High-Risk Patients: A First-in-Human Multiple-Dose, Randomized Controlled Trial.

Clin Transl Sci 2017 Nov 9;10(6):455-469. Epub 2017 Aug 9.

Department of Medicine, Division of Translational Medicine and Human Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cts.12487DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5673907PMC
November 2017

Tobacco Smoke Exposure Reduces Paraoxonase Activity in a Murine Model.

Int J Biomed Sci 2017 03;13(1):20-25

Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, 1830 E. Monument Street, Baltimore, Maryland 21287, United States.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5422641PMC
March 2017

Apolipoprotein E-/- Mice Lacking Hemopexin Develop Increased Atherosclerosis via Mechanisms That Include Oxidative Stress and Altered Macrophage Function.

Arterioscler Thromb Vasc Biol 2016 06 14;36(6):1152-63. Epub 2016 Apr 14.

From the Department of Molecular and Medical Pharmacology (N.U.M., S.T.R.) and Division of Cardiology, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles (N.U.M., V.G., S.H., A.W., M.N., A.M.F., S.T.R.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/ATVBAHA.115.306991DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4882257PMC
June 2016

Tg6F ameliorates the increase in oxidized phospholipids in the jejunum of mice fed unsaturated LysoPC or WD.

J Lipid Res 2016 05 9;57(5):832-47. Epub 2016 Mar 9.

Departments of Medicine, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA 90095-1736.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1194/jlr.M064352DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847630PMC
May 2016

Carboxyl-Terminal Cleavage of Apolipoprotein A-I by Human Mast Cell Chymase Impairs Its Anti-Inflammatory Properties.

Arterioscler Thromb Vasc Biol 2016 Feb 17;36(2):274-84. Epub 2015 Dec 17.

From the Wihuri Research Institute, Biomedicum Helsinki, Helsinki, Finland (S.D.N., K.M., J.L., K.N., K.Ö., M.L.-R., P.T.K.); National Institute for Health and Welfare, Genomics and Biomarkers Unit, Biomedicum Helsinki, Helsinki, Finland (J.M., M.J.); and Division of Cardiology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles (M.N., A.M.F.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/ATVBAHA.115.306827DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4725095PMC
February 2016

Endothelial NOTCH1 is suppressed by circulating lipids and antagonizes inflammation during atherosclerosis.

J Exp Med 2015 Nov 9;212(12):2147-63. Epub 2015 Nov 9.

Department of Molecular, Cell, and Developmental Biology, University of California, Los Angeles, Los Angeles, CA 90095 Molecular Biology Institute, University of California, Los Angeles, Los Angeles, CA 90095

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1084/jem.20150603DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4647265PMC
November 2015

Efficacy of tomato concentrates in mouse models of dyslipidemia and cancer.

Pharmacol Res Perspect 2015 Aug 24;3(4):e00154. Epub 2015 Jun 24.

Division of Cardiology, Department of Medicine, David Geffen School of Medicine at UCLA Los Angeles, California, 90095-1736 ; Department of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA Los Angeles, California, 90095-1736 ; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA Los Angeles, California, 90095-1736.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/prp2.154DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4492730PMC
August 2015

Small lipidated anti-obesity compounds derived from neuromedin U.

Eur J Med Chem 2015 Aug 14;101:616-26. Epub 2015 Jul 14.

Department of Psychiatry and Biobehavioral Sciences, University of California at Los Angeles, 760 Westwood Plaza, Los Angeles, CA 90024, USA; The Pasarow Mass Spectrometry Laboratory, The Jane and Terry Semel Institute for Neuroscience and Human Behavior, 760 Westwood Plaza, Los Angeles, CA 90024, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejmech.2015.07.020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4543588PMC
August 2015

Adipocyte phospholipid transfer protein and lipoprotein metabolism.

Arterioscler Thromb Vasc Biol 2015 Feb 4;35(2):316-22. Epub 2014 Dec 4.

From the Department of Cell Biology, State University of New York, Downstate Medical Center, Brooklyn (H.J., A.Y., Y.C., X.Z., R.L., Z.L., W.J., X.C.J.); Fudan University, Shanghai, China (B.L., Y.C.); Molecular and Cellular Cardiology Program, VA New York Harbor Healthcare System, New York (Z.L., X.C.J); Institute of Atherosclerosis, Taishan Medical University, Taian, China (X.Z., S.Q.); Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN (H.H.B., M.S.K.); and Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA (M.N.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/ATVBAHA.114.303764DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4304886PMC
February 2015

Apolipoprotein A-I mimetic peptide 4F rescues pulmonary hypertension by inducing microRNA-193-3p.

Circulation 2014 Aug 24;130(9):776-85. Epub 2014 Jun 24.

From the Department of Anesthesiology, Division of Molecular Medicine (S.S., S.U., A.I., G.W., D. Mai, K.N., M.E.), Department of Medicine, Division of Cardiology (D. Meriwether, K.N., M.N., A.M.F., S.T.R.), Division of Pulmonary Critical Care Medicine (D.R.), Department of Molecular and Medical Pharmacology (S.T.R.), and Cardiovascular Research Laboratories (M.E.), David Geffen School of Medicine at University of California-Los Angeles; and Pulmonary Hypertension Research Group, Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Laval University, Québec, Canada (F.P., S.B.-B., S.P., S.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.114.007405DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4194270PMC
August 2014

Apolipoprotein A-I mimetics.

Curr Opin Lipidol 2014 Aug;25(4):304-8

aDepartment of Medicine bDepartment of Obstetrics and Gynecology cDepartment of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California dDepartment of Medicine, University of Alabama at Birmingham, Alabama USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOL.0000000000000092DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4213064PMC
August 2014

Searching for a successful HDL-based treatment strategy.

Biochim Biophys Acta 2014 Jan;1841(1):162-7

View Article

Download full-text PDF

Source
January 2014

Heart failure is associated with impaired anti-inflammatory and antioxidant properties of high-density lipoproteins.

Am J Cardiol 2013 Dec 16;112(11):1770-7. Epub 2013 Sep 16.

Division of Cardiology, Department of Medicine of David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2013.07.045DOI Listing
December 2013

Protection against ischemia/reperfusion injury by high-density lipoprotein and its components.

Circ Res 2013 Dec;113(12):1281-2

From the Departments of Medicine (A.M.F., S.T.R., M.N.), Obstetrics and Gynecology (S.T.R.), and Molecular and Medical Pharmacology (S.T.R.), David Geffen School of Medicine at UCLA, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCRESAHA.113.302943DOI Listing
December 2013

Ambient ultrafine particles reduce endothelial nitric oxide production via S-glutathionylation of eNOS.

Biochem Biophys Res Commun 2013 Jul 7;436(3):462-6. Epub 2013 Jun 7.

Biomedical Engineering, University of Southern California, Los Angeles, CA 90089, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2013.05.127DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3743434PMC
July 2013

Diesel exhaust induces systemic lipid peroxidation and development of dysfunctional pro-oxidant and pro-inflammatory high-density lipoprotein.

Arterioscler Thromb Vasc Biol 2013 Jun 4;33(6):1153-61. Epub 2013 Apr 4.

Department of Medicine, Division of Cardiology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/ATVBAHA.112.300552DOI Listing
June 2013

Reducing plasma cholesterol is not the end of the quest.

Atherosclerosis 2013 Mar 9;227(1):35-6. Epub 2013 Jan 9.

Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, 10833 Le Conte Ave., Los Angeles, CA 90095-1679, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.atherosclerosis.2012.12.034DOI Listing
March 2013

Atmospheric ultrafine particles promote vascular calcification via the NF-κB signaling pathway.

Am J Physiol Cell Physiol 2013 Feb 12;304(4):C362-9. Epub 2012 Dec 12.

Biomedical Engineering and Cardiovascular Medicine, University of Southern California, Los Angeles, CA 90089, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1152/ajpcell.00322.2012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566535PMC
February 2013

Vasculitis, Atherosclerosis, and Altered HDL Composition in Heme-Oxygenase-1-Knockout Mice.

Int J Hypertens 2012 20;2012:948203. Epub 2012 Feb 20.

The First Department of Internal Medicine and Center for Medical Education and Career Development, Fukushima Medical University, 1 Hikarigaoka, Fukushima 960-1625, Japan.

View Article

Download full-text PDF

Source
http://www.hindawi.com/journals/ijhy/2012/948203/
Publisher Site
http://dx.doi.org/10.1155/2012/948203DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3296294PMC
August 2012

Apolipoprotein A-I mimetic peptides inhibit expression and activity of hypoxia-inducible factor-1α in human ovarian cancer cell lines and a mouse ovarian cancer model.

J Pharmacol Exp Ther 2012 Aug 25;342(2):255-62. Epub 2012 Apr 25.

Department of Obstetrics/Gynecology, University of California, 650 Charles E. Young Drive South, CHS 24-127, Los Angeles, CA 90095, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1124/jpet.112.191544DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3400800PMC
August 2012

Effects of lipid-probe interactions in biochemical fluorometric methods that assess HDL redox activity.

Lipids Health Dis 2012 Jul 6;11:87. Epub 2012 Jul 6.

Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1476-511X-11-87DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3409024PMC
July 2012

HDL mimetics inhibit tumor development in both induced and spontaneous mouse models of colon cancer.

Mol Cancer Ther 2012 Jun 13;11(6):1311-9. Epub 2012 Mar 13.

Department of Obstetrics and Gynecology, University of California Los Angeles, Los Angeles, CA 90095, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-11-0905DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3374063PMC
June 2012

A biochemical fluorometric method for assessing the oxidative properties of HDL.

J Lipid Res 2011 Dec 27;52(12):2341-51. Epub 2011 Sep 27.

Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1194/jlr.D018937DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3220300PMC
December 2011

The effect of HDL mimetic peptide 4F on PON1.

Adv Exp Med Biol 2010 ;660:167-72

David Geffen School of Medicine, University of California, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/978-1-60761-350-3_15
Publisher Site
http://dx.doi.org/10.1007/978-1-60761-350-3_15DOI Listing
September 2011

Chronic inflammatory disorders and accelerated atherosclerosis: chronic kidney disease.

Curr Pharm Des 2011 ;17(1):17-20

David Geffen School of Medicine, 10833 Le Conte Ave., University of California Los Angeles, CA 90095, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/138161211795049787DOI Listing
July 2011

Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally.

J Lipid Res 2011 Jun 28;52(6):1200-10. Epub 2011 Mar 28.

Department of Medicine, David Geffen School of Medicine at the University of California, Los Angeles, CA 90095, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1194/jlr.M013144DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3090241PMC
June 2011

HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms.

Nat Rev Cardiol 2011 Apr 8;8(4):222-32. Epub 2011 Feb 8.

Department of Medicine, David Geffen School of Medicine, UCLA, 10833 Le Conte Avenue, Los Angeles, CA 90095-1679, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrcardio.2010.222DOI Listing
April 2011

HIV-1 infected patients with suppressed plasma viremia on treatment have pro-inflammatory HDL.

Lipids Health Dis 2011 Feb 23;10:35. Epub 2011 Feb 23.

Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1476-511X-10-35DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3049748PMC
February 2011

L-4F differentially alters plasma levels of oxidized fatty acids resulting in more anti-inflammatory HDL in mice.

Drug Metab Lett 2010 Aug;4(3):139-48

Department of Medicine, and David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-1679, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3037264PMC
August 2010

HDL metabolism and activity in chronic kidney disease.

Nat Rev Nephrol 2010 May 23;6(5):287-96. Epub 2010 Mar 23.

Division of Nephrology and Hypertension, School of Medicine, The City Drive, City Tower, Suite 400, Orange, CA 92868-3217, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrneph.2010.36DOI Listing
May 2010

Oxpholipin 11D: an anti-inflammatory peptide that binds cholesterol and oxidized phospholipids.

PLoS One 2010 Apr 14;5(4):e10181. Epub 2010 Apr 14.

Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0010181PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2854715PMC
April 2010

Structure and function of HDL mimetics.

Arterioscler Thromb Vasc Biol 2010 Feb 16;30(2):164-8. Epub 2009 Jul 16.

Division of Cardiology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-1679, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/ATVBAHA.109.187518DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2860541PMC
February 2010

L-4F alters hyperlipidemic (but not healthy) mouse plasma to reduce platelet aggregation.

Arterioscler Thromb Vasc Biol 2010 Feb 3;30(2):283-9. Epub 2009 Dec 3.

Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, Calif 90095-1679, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/ATVBAHA.109.200162DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2818809PMC
February 2010

HDL as a biomarker, potential therapeutic target, and therapy.

Diabetes 2009 Dec;58(12):2711-7

Department of Medicine, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/db09-0538DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2780869PMC
December 2009

A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids.

J Lipid Res 2009 Aug 18;50(8):1538-47. Epub 2009 Feb 18.

Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095-1679, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1194/jlr.M800539-JLR200DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2724044PMC
August 2009

Hemoglobin and its scavenger protein haptoglobin associate with apoA-1-containing particles and influence the inflammatory properties and function of high density lipoprotein.

J Biol Chem 2009 Jul 11;284(27):18292-301. Epub 2009 May 11.

Atherosclerosis Research Unit, Department of Medicine/Cardiology, University of California, Los Angeles, California 90095, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M109.017202DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2709397PMC
July 2009

The role of dysfunctional HDL in atherosclerosis.

J Lipid Res 2009 Apr 27;50 Suppl:S145-9. Epub 2008 Oct 27.

Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-1679, USA.

View Article

Download full-text PDF

Source
http://www.jlr.org/content/50/Supplement/S145.full.pdf
Web Search
http://www.jlr.org/cgi/doi/10.1194/jlr.R800036-JLR200
Publisher Site
http://dx.doi.org/10.1194/jlr.R800036-JLR200DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2674720PMC
April 2009

Apolipoprotein A-I mimetic peptides.

Curr Atheroscler Rep 2009 Jan;11(1):52-7

Division of Cardiology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.

View Article

Download full-text PDF

Source
http://atvb.ahajournals.org/content/25/7/1325.full.pdf
Web Search
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2856617PMC
January 2009

Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I.

J Lipid Res 2008 Nov 11;49(11):2302-11. Epub 2008 Jul 11.

Department of Medicine David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095-1679, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1194/jlr.M800075-JLR200DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2563211PMC
November 2008

Multiple indications for anti-inflammatory apolipoprotein mimetic peptides.

Curr Opin Investig Drugs 2008 Nov;9(11):1157-62

David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-1679, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2856620PMC
November 2008

Host-derived oxidized phospholipids and HDL regulate innate immunity in human leprosy.

J Clin Invest 2008 Aug;118(8):2917-28

Division of Cardiology, Molecular Biology Institute, Department of Microbiology, Immunology, and Molecular Genetics, UCLA David Geffen School of Medicine, Howard Hughes Medical Institute, Los Angeles, California 90095, USA.

View Article

Download full-text PDF

Source
http://www.jci.org/articles/view/34189
Publisher Site
http://dx.doi.org/10.1172/JCI34189DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2467381PMC
August 2008

Inflammation and metabolic disorders.

Curr Opin Clin Nutr Metab Care 2008 Jul;11(4):459-64

Division of Cardiology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California 90095, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MCO.0b013e32830460c2DOI Listing
July 2008

Treatment with an apolipoprotein A-1 mimetic peptide in combination with pravastatin inhibits collagen-induced arthritis.

Clin Immunol 2008 May 12;127(2):234-44. Epub 2008 Mar 12.

Division of Rheumatology, at the UCLA David Geffen School of Medicine, 1000 Veteran Avenue, Room 32-59, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clim.2008.01.016DOI Listing
May 2008

Proatherogenic high-density lipoprotein, vascular inflammation, and mimetic peptides.

Curr Atheroscler Rep 2008 Apr;10(2):171-6

Division of Cardiology, Department of Medicine, David Geffen School of Medicine at UCLA, 10833 Le Conte Avenue, Los Angeles, CA 90095, USA.

View Article

Download full-text PDF

Source
April 2008

Ambient particulate pollutants in the ultrafine range promote early atherosclerosis and systemic oxidative stress.

Circ Res 2008 Mar 17;102(5):589-96. Epub 2008 Jan 17.

Department of Medicine, David Geffen School of Medicine, 10833 Le Conte Ave, CHS 52-175, Box 951680, Los Angeles, CA 90095, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCRESAHA.107.164970DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3014059PMC
March 2008

Apo A-1 mimetic peptides as atheroprotective agents in murine models.

Curr Drug Targets 2008 Mar;9(3):204-9

Department of Medicine, David Geffen School of Medicine at UCLA, 10833 Le Conte Avenue, Los Angeles, California 90095-1679, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/138945008783755584DOI Listing
March 2008

The effect of apolipoprotein mimetic peptides in inflammatory disorders other than atherosclerosis.

Trends Cardiovasc Med 2008 Feb;18(2):61-6

Division of Cardiology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-1679, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tcm.2007.12.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4365994PMC
February 2008

D-4F reduces EO6 immunoreactivity, SREBP-1c mRNA levels, and renal inflammation in LDL receptor-null mice fed a Western diet.

J Lipid Res 2008 Jan 9;49(1):192-205. Epub 2007 Oct 9.

Department of Medicine, David Geffen School of Medicine at the University of California-Los Angeles, Los Angeles, CA 90095-1679, USA.

View Article

Download full-text PDF

Source
http://www.jlr.org/lookup/doi/10.1194/jlr.M700433-JLR200
Publisher Site
http://dx.doi.org/10.1194/jlr.M700433-JLR200DOI Listing
January 2008

Lipoprotein inflammatory properties and serum amyloid A levels but not cholesterol levels predict lesion area in cholesterol-fed rabbits.

J Lipid Res 2007 Nov 10;48(11):2344-53. Epub 2007 Aug 10.

Department of Medicine, David Geffen School of Medicine at the University of California at Los Angeles, Los Angeles, CA 90095-1679, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1194/jlr.M700138-JLR200DOI Listing
November 2007

Structural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-I mimetic peptides.

J Lipid Res 2007 Sep 14;48(9):1915-23. Epub 2007 Jun 14.

Department of Medicine, Biochemistry, and Molecular Genetics and Atherosclerosis Research Unit, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

View Article

Download full-text PDF

Source
http://www.jlr.org/lookup/doi/10.1194/jlr.R700010-JLR200
Publisher Site
http://dx.doi.org/10.1194/jlr.R700010-JLR200DOI Listing
September 2007

High-density lipoprotein: antioxidant and anti-inflammatory properties.

Curr Atheroscler Rep 2007 Sep;9(3):244-8

Division of Cardiology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-1679, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s11883-007-0026
Web Search
September 2007

A novel anti-atherogenic role for COX-2--potential mechanism for the cardiovascular side effects of COX-2 inhibitors.

Prostaglandins Other Lipid Mediat 2007 Aug 14;84(1-2):24-33. Epub 2007 Mar 14.

Department of Molecular and Medical Pharmacology, University of California Los Angeles, CA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.prostaglandins.2007.03.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701232PMC
August 2007

Adenovirus-mediated expression of human paraoxonase 3 protects against the progression of atherosclerosis in apolipoprotein E-deficient mice.

Arterioscler Thromb Vasc Biol 2007 Jun 19;27(6):1368-74. Epub 2007 Apr 19.

Atherosclerosis Research Unit, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, Calif 90095, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/ATVBAHA.106.134189DOI Listing
June 2007

Oxidation hypothesis of atherogenesis: HDL inflammatory index and apolipoprotein A-I mimetic peptides.

Future Cardiol 2007 May;3(3):309-19

UCLA-San Fernando Valley, Program at Olive View-UCLA Medical Center, Department of Medicine, CA, USA.

View Article

Download full-text PDF

Source
https://www.futuremedicine.com/doi/10.2217/14796678.3.3.309
Publisher Site
http://dx.doi.org/10.2217/14796678.3.3.309DOI Listing
May 2007

Peptide Mimetics of Apolipoproteins Improve HDL Function.

J Clin Lipidol 2007 May;1(2):142-7

David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-1679.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacl.2007.03.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2130772PMC
May 2007

High-density lipoprotein cholesterol: an emerging target for stroke treatment.

Stroke 2007 Mar 25;38(3):1104-9. Epub 2007 Jan 25.

Department of Neurology, University of Southern California, Los Angeles, CA 90033, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/01.STR.0000258347.19449.0fDOI Listing
March 2007

Modifying the anti-inflammatory effects of high-density lipoprotein.

Curr Atheroscler Rep 2007 Jan;9(1):57-63

Department of Medicine, David Geffen School of Medicine at UCLA, 100 UCLA Medical Plaza, Suite 525, Los Angeles, CA 90095, USA.

View Article

Download full-text PDF

Source
January 2007

Adenovirus mediated expression of human paraoxonase 2 protects against the development of atherosclerosis in apolipoprotein E-deficient mice.

Mol Genet Metab 2006 Dec 28;89(4):368-73. Epub 2006 Aug 28.

Atherosclerosis Research Unit, Division of Cardiology, Department of Medicine, 47-123 CHS, Los Angeles, CA 90095, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ymgme.2006.07.004DOI Listing
December 2006

D-4F decreases brain arteriole inflammation and improves cognitive performance in LDL receptor-null mice on a Western diet.

J Lipid Res 2006 Oct 11;47(10):2148-60. Epub 2006 Jul 11.

Department of Medicine, David Geffen School of Medicine at the University of California-Los Angeles, Los Angeles, CA 90095-1679, USA.

View Article

Download full-text PDF

Source
http://www.jlr.org/lookup/doi/10.1194/jlr.M600214-JLR200
Publisher Site
http://dx.doi.org/10.1194/jlr.M600214-JLR200DOI Listing
October 2006

Apolipoprotein A-I mimetic peptides and their role in atherosclerosis prevention.

Nat Clin Pract Cardiovasc Med 2006 Oct;3(10):540-7

Division of Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncpcardio0661DOI Listing
October 2006

Mechanisms of disease: proatherogenic HDL--an evolving field.

Nat Clin Pract Endocrinol Metab 2006 Sep;2(9):504-11

Division of Cardiology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-1679, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncpendmet0245DOI Listing
September 2006

Potential clinical utility of high-density lipoprotein-mimetic peptides.

Curr Opin Lipidol 2006 Aug;17(4):440-4

David Geffen School of Medicine at UCLA, Los Angeles, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.mol.0000236371.27508.d4DOI Listing
August 2006

Synthetic peptides: managing lipid disorders.

Curr Opin Lipidol 2006 Jun;17(3):233-7

Departments of Medicine, Biochemistry, and Molecular Genetics and the Atherosclerosis Research Unit, University of Alabama at Birmingham, Birmingham Alabama, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.mol.0000226114.89812.75DOI Listing
June 2006

Oral amphipathic peptides as therapeutic agents.

Expert Opin Investig Drugs 2006 Jan;15(1):13-21

Division of Cardiology, Department of Medicine, David Geffen School of Medicine, UCLA, Los Angeles, California 90095-1679, USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1517/13543784.15.1.13
Publisher Site
http://dx.doi.org/10.1517/13543784.15.1.13DOI Listing
January 2006

High-density lipoprotein function recent advances.

J Am Coll Cardiol 2005 Nov 19;46(10):1792-8. Epub 2005 Oct 19.

Atherosclerosis Research Unit, Division of Cardiology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2005.06.080DOI Listing
November 2005